PAM
AGN

Panagora Asset Management’s Allergan Inc AGN Stock Holding History

Panagora Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-65,896
Closed -$14M – 2486
2014
Q4 		$14M Sell
65,896
-10,016
-13% -$1.99M 0.07% 263
2014
Q3 		$13.5M Sell
75,912
-40,169
-35% -$6.67M 0.07% 282
2014
Q2 		$19.6M Buy
116,081
+94,618
+441% +$14.7M 0.1% 199
2014
Q1 		$2.66M Sell
21,463
-390
-2% -$47.5K 0.01% 754
2013
Q4 		$2.43M Sell
21,853
-1,534
-7% -$147K 0.01% 781
2013
Q3 		$2.12M Sell
23,387
-446
-2% -$40K 0.01% 795
2013
Q2 		$2.01M Buy
+23,833
New +$2.47M 0.01% 776

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Panagora Asset Management's AGN Position: Q1 2015 in Review

Panagora Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 65,896 shares — an estimated $14M sold.

Panagora Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $19.6M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Panagora Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Panagora Asset Management sold 65,896 Allergan Inc shares in Q1 2015, an estimated $14M.
  • Panagora Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Panagora Asset Management's Allergan Inc position peaked at $19.6M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Panagora Asset Management's 13F filing for Q1 2015, filed 15 May 2015.